Viewing Study NCT05690204

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:56 PM
Ignite Modification Date: 2026-05-15 @ 6:37 PM
Study NCT ID: NCT05690204
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-11-14
First Post: 2022-12-12
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Dose Finding Study to Evaluate Safety and Efficacy of 3 Dosages of SAP 001.
Sponsor: Shanton Pharma Pte. Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gout View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hyperuricemia View
None Serum Uric Acid View
None Gout Flare View